Yearly Archives: 2023

Mallinckrodt and Endo have entered into a definitive agreement to combine in a $6.7 billion deal, after the companies emerged from bankruptcy in connection...

Merck (known as MSD outside of the United States and Canada) has opened a new, $1 billion, 225,000 sq ft facility dedicated to vaccine...

Ono Pharmaceutical has entered into a license agreement with Ionis Pharmaceuticals for sapablursen, an investigational RNA-targeted medicine for the treatment of polycythemia vera (PV). Sapablursen...